Friday, March 11, 2022

Strides Pharma unit gets USFDA for generic product

Strides Pharma unit gets USFDA for generic product Singapore-based Strides Pharma Global Pte, a step down wholly-owned subsidiary of the company, has received approval from the United States Food Drug Administration (USFDA) to market the product, Strides Pharma Science said in a statement.

from Moneycontrol Business News https://ift.tt/Sh4IJR2
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...